Showing results (331-340 of 586) with videos related to
Sort By:
Pageof 59
Journal of Cardiovascular Pharmacology|September 11, 1998
Pharmacokinetics and pharmacodynamics of sibrafiban (Ro 48-3657), an orally active IIb/IIIa antagonist, administered alone or in combination with heparin, aspirin, and recombinant tissue-type plasminogen activator in beaglesN B Modi, Y S Lin, T Reynolds, et al.Physical Chemistry Chemical Physics : PCCP|April 11, 2015
Enhanced electrical properties at boundaries including twin boundaries of polycrystalline CdTe thin-film solar cellsH Li, X X Liu, Y S Lin, et al.The Biochemical Journal|July 15, 1978
Evidence for the involvement of superoxide in vitamin K-dependent carboxylation of glutamic acid residues of prothrombinM P Esnouf, M R Green, H A Hill, et al.Cancer|February 19, 1999
Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?J E Herndon, S Fleishman, A B Kornblith, et al.Journal of the American Society for Mass Spectrometry|November 9, 2013
Peptide sequence determination by matrix-assisted laser desorption ionization employing a tandem double focusing magnetic-Orthogonal acceleration time-of-flight mass spectrometerK F Medzihradszky, G W Adams, A L Burlingame, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 1, 1995
Immunohistochemical evaluation of E-cadherin and epidermal growth factor receptor in non-small cell lung cancerS M Sorscher, V Russack, S Graziano, et al.The British Journal of Dermatology|August 1, 1997
The epidermal nerve fibre network: characterization of nerve fibres in human skin by confocal microscopy and assessment of racial variationsD M Reilly, D Ferdinando, C Johnston, et al.Cancer Treatment Reports|May 1, 1987
High-dose etoposide therapy for extensive small cell lung cancer: a Cancer and Leukemia Group B StudyS D Luikart, K J Propert, C R Modeas, et al.Lung Cancer (Amsterdam, Netherlands)|October 27, 2001
High-dose doxorubicin, dexrazoxane, and GM-CSF in malignant mesothelioma: a phase II study-Cancer and Leukemia Group B 9631M P Kosty, J E Herndon, N J Vogelzang, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a Cancer and Leukemia Group B studyH Kreisman, M Goutsou, C Modeas, et al.Pageof 59